These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 16532448)
1. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Tarsy D; Baldessarini RJ Mov Disord; 2006 May; 21(5):589-98. PubMed ID: 16532448 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs. Tarsy D; Lungu C; Baldessarini RJ Handb Clin Neurol; 2011; 100():601-16. PubMed ID: 21496610 [TBL] [Abstract][Full Text] [Related]
3. Motor and mental side effects of clozapine. Gerlach J; Peacock L J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551 [TBL] [Abstract][Full Text] [Related]
4. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia. Andrew HG Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668 [TBL] [Abstract][Full Text] [Related]
5. The prevalence of akathisia in patients receiving stable doses of clozapine. Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271 [TBL] [Abstract][Full Text] [Related]
6. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment. Modestin J; Wehrli MV; Stephan PL; Agarwalla P Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180 [TBL] [Abstract][Full Text] [Related]
7. A summary of current knowledge of tardive dyskinesia. Baldessarini RJ Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654 [TBL] [Abstract][Full Text] [Related]
8. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality. Modestin J; Vogt Wehrli M; Stephan PL; Agarwalla P Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879 [TBL] [Abstract][Full Text] [Related]
12. Non-therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: a meta-analysis. Tenback DE; van Harten PN; van Os J Mov Disord; 2009 Dec; 24(16):2309-15. PubMed ID: 19645070 [TBL] [Abstract][Full Text] [Related]
15. Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Nasrallah HA Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454 [TBL] [Abstract][Full Text] [Related]
16. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. Glazer WM; Morgenstern H; Doucette JT J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030 [TBL] [Abstract][Full Text] [Related]
17. Preventing neuroleptic-induced tardive dyskinesia in adults and children. Lam RW; Jeste SD; Jeste DV Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652 [TBL] [Abstract][Full Text] [Related]
18. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics. Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047 [TBL] [Abstract][Full Text] [Related]
19. [Tardive dyskinesia: review of the literature]. Carta MG; Hardoy MC; Dell'Osso L; Carpiniello B Clin Ter; 2004 Apr; 155(4):127-33. PubMed ID: 15354761 [TBL] [Abstract][Full Text] [Related]